Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] SK hynix(000660) – Investor Relations (IR) Presentation / 2024-01-09

Posted on January 9, 2024July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] SK hynix(000660) – Investor Relations (IR) Presentation / 2024-01-09

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

SK hynix will hold an Investor Relations (IR) presentation via conference call on January 25, 2024, at 09:00 AM KST to announce its Q4 2023 financial results.

📊 [Key Disclosure Details & Financial Summary]

  • Investor Relations (IR) Overview
    • Date & Time: January 25, 2024, at 09:00 AM KST
    • Location: N/A (Conducted via Conference Call)
    • Target Audience: Investors and Media
    • Purpose: Announcement of Q4 2023 financial results
  • Event Format & Host
    • Format: Conference Call (Simultaneous live Korean/English webcasting provided via official website)
    • Host/Sponsor: Self-hosted
    • Decision Date: January 09, 2024
  • Main Agenda & Material Posting
    • Main Agenda: Q4 2023 earnings report and Q&A session
    • Presentation Material Posting Date: January 25, 2024 (Available on the company website under Earnings Release)
    • Related Website: http://www.skhynix.com

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Provisional Earnings Disclosure and IR Materials on Event Date

This disclosure provides advance notice regarding the scheduled IR conference call to present Q4 2023 financial performance. Checking the provisional earnings numbers disclosed on the presentation date alongside the official IR materials is important for evaluating quarterly operating performance and business outlook. Specific financial results can be verified in the ‘Provisional Operating Results (Fair Disclosure)’ filing published on the earnings date, as well as the IR materials section of the official company website.

📢 Disclaimer & Fact Source

Source: This content was newly generated and structured based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy/sell specific stocks. All investment decisions and financial responsibilities lie entirely with the investor.

Contact Us: For compliance queries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Wonik IPS (240810) – Change of Chief Executive Officer (CEO) / 2024-01-02
Next Post: [Disclosure] Samsung Electronics (005930) – Investor Relations (IR) Holding Announcement / 2024-01-09

Related Posts

[Disclosure] Hanwha Ocean (042660) – Decision on Loan to Others / 2025-09-10 Disclosures
[Disclosure] Hanwha Systems (272210) – Publishes 2024 Sustainability Report (Voluntary Disclosure) Disclosures
[Disclosure] ALTEOGEN (196170) – Trading Suspension and Resumption of Stock Futures and Options / 2026-07-16 Disclosures
[Disclosure] SK hynix (000660) – (Correction) Decision on Loan of Funds / 2025-04-23 Semiconductors
[Disclosure] Samsung Electronics (005930) – (Correction) Long-term Business and Management Plan (Fair Disclosure) / 2026-06-29 Semiconductors
[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-up Plan (Voluntary Disclosure) / 2025-04-11 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme